The global Bone Graft Substitutes Market had a value of USD 3.0 billion in 2022. It is projected to reach USD 5.16 billion by 2032, exhibiting a revenue CAGR of 6.2% during the forecast period. Key drivers of this market growth include the increasing elderly population, higher prevalence of bone-related ailments and injuries, and advancements in bone grafting techniques and materials. Artificial bone grafts are commonly used in orthopedic treatments such as spinal fusion, joint repair, and trauma surgeries as replacements or supplements to natural bone.